The pharmaceutical industry faces an innovation crisis with declining R&D productivity, rising costs, and regulatory challenges impacting drug development.

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) ('Ligand”) announced today the pricing of $400.0 million aggregate ...

The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere to ...

The demand for renal transplant therapeutics is increasing due to several important factors. Chief among these is the global rise in kidney transplan ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Archer Daniels Midland logged lower profit and revenue in the second quarter, hurt by what Chief Executive Juan Luciano called a challenging environment. Yum Brands logged higher profit and sales in ...

Archer Daniels Midland logged lower profit and revenue in the second quarter, hurt by what Chief Executive Juan Luciano called a challenging environment. Yum Brands logged higher profit and sales in ...

Pfizer Inc (NYSE: PFE) saw its shares rise by more than 4% after the company reported strong second-quarter results that ...

Pfizer CEO Albert Bourla is expected to attend a $25 million fundraiser at US President Donald Trump’s golf club in ...

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

President Donald Trump sent letters to 17 pharmaceutical companies Thursday, urging them to match drug prices to the lowest ...